Citations

1. Centers for Disease Control and Prevention (2006). Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 55(RR-10): 1–44. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr55e628a1.htm. [Erratum: (2006). MMWR, 55(RR-10): 743. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5529a4.htm.]

2. Centers for Disease Control and Prevention (2002). Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 51(RR-03): 1–31.

3. Uyeki T, Winquist A (2001). Influenza. Clinical Evidence (6): 550–556.

4. Centers for Disease Control and Prevention (2006). CDC Health Alert: CDC Recommends Against the Use of Amantadine and Rimantadine for the Treatment or Prophylaxis of Influenza in the United States During the 2005–06 Influenza Season. Available online: http://www.cdc.gov/flu/han011406.htm.

5. Centers for Disease Control and Prevention (2004). Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR, 53(RR-6): 1–44. Also available online: http://www.cdc.gov/mmwr/PDF/RR/RR5306.pdf. [Erratum: (2004). MMWR, 53(RR-6): 743. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5332a8.htm.]

6. Hayden FG, et al. (2000). Inhaled zanamivir for the prevention of influenza in families. New England Journal of Medicine, 343(18): 1282–1289.